- Home
- TXG vs PK Comparison
TXG vs PK Comparison
Compare TXG & PK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- PK
- Stock Information
- Founded
- TXG 2012
- PK 1946
- Country
- TXG United States
- PK United States
- Employees
- TXG N/A
- PK N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- PK Real Estate Investment Trusts
- Sector
- TXG Industrials
- PK Real Estate
- Exchange
- TXG Nasdaq
- PK Nasdaq
- Market Cap
- TXG 1.7B
- PK 2.1B
- IPO Year
- TXG 2019
- PK N/A
- Fundamental
- Price
- TXG $13.36
- PK $10.91
- Analyst Decision
- TXG Buy
- PK Hold
- Analyst Count
- TXG 11
- PK 11
- Target Price
- TXG $13.41
- PK $12.85
- AVG Volume (30 Days)
- TXG 3.6M
- PK 4.1M
- Earning Date
- TXG 08-07-2025
- PK 07-31-2025
- Dividend Yield
- TXG N/A
- PK 12.83%
- EPS Growth
- TXG N/A
- PK N/A
- EPS
- TXG N/A
- PK 0.28
- Revenue
- TXG $644,466,000.00
- PK $2,589,000,000.00
- Revenue This Year
- TXG N/A
- PK $2.07
- Revenue Next Year
- TXG $5.60
- PK $2.55
- P/E Ratio
- TXG N/A
- PK $39.16
- Revenue Growth
- TXG 2.02
- PK N/A
- 52 Week Low
- TXG $6.78
- PK $8.27
- 52 Week High
- TXG $24.76
- PK $16.23
- Technical
- Relative Strength Index (RSI)
- TXG 55.08
- PK 54.04
- Support Level
- TXG $12.85
- PK $10.08
- Resistance Level
- TXG $14.22
- PK $11.20
- Average True Range (ATR)
- TXG 0.94
- PK 0.34
- MACD
- TXG -0.09
- PK 0.04
- Stochastic Oscillator
- TXG 52.02
- PK 72.73
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels with 22,711 rooms across 37 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.